Scarica l'app Stockscreener
23.27
0.30%
-0.07
Dopo l'orario di chiusura:
23.27
Precedente Chiudi:
$23.34
Aprire:
$23.28
Volume 24 ore:
147.18K
Relative Volume:
0.64
Capitalizzazione di mercato:
$719.33M
Reddito:
$290.71M
Utile/perdita netta:
$-163.43M
Rapporto P/E:
-4.2464
EPS:
-5.48
Flusso di cassa netto:
$11.70M
1 W Prestazione:
+1.31%
1M Prestazione:
-17.13%
6M Prestazione:
+7.88%
1 anno Prestazione:
+34.12%
Intervallo 1D:
$22.85
$23.39
Intervallo di 1 settimana:
$22.82
$23.83
Portata 52W:
$14.76
$31.04
Fulgent Genetics Inc Stock (FLGT) Company Profile
Nome
Fulgent Genetics Inc
Settore
Industria
Telefono
626-350-0537
Indirizzo
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
23.27 | 721.50M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
515.12 | 192.95B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
211.25 | 147.43B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
630.73 | 50.70B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
126.34 | 35.90B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
328.66 | 32.13B | 3.17B | 642.63M | 539.81M | 10.77 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-05 | Aggiornamento | UBS | Neutral → Buy |
| 2023-12-07 | Iniziato | UBS | Neutral |
| 2022-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | Iniziato | Raymond James | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-02-04 | Ripresa | Piper Sandler | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Underperform |
| 2021-01-08 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-08-20 | Iniziato | Oppenheimer | Outperform |
| 2020-05-29 | Iniziato | BTIG Research | Buy |
| 2019-11-05 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
Mostra tutto
Fulgent Genetics Inc Borsa (FLGT) Ultime notizie
RSI Check: What is the long term forecast for Fulgent Genetics Inc stock2025 Market Outlook & Growth-Oriented Investment Plans - baoquankhu1.vn
Will Fulgent Genetics Inc. outperform small cap indexesJuly 2025 Price Swings & Weekly High Return Stock Opportunities - mfd.ru
Aug Technicals: Can Fulgent Genetics Inc stock outperform in a bear marketQuarterly Investment Review & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Allianz Asset Management GmbH Increases Stake in Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics, Inc. (FLGT) Stock Analysis: Exploring a 46% Potential Upside Amid Diagnostic and Therapeutic Growth - DirectorsTalk Interviews
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026 - marketscreener.com
Press Release: Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026 - 富途牛牛
Fulgent Genetics (NASDAQ:FLGT) Cut to Hold at Zacks Research - Defense World
Fulgent Genetics (NASDAQ:FLGT) Stock Rating Lowered by Zacks Research - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) versus Privia Health Group (NASDAQ:PRVA) Critical Contrast - Defense World
What’s the analyst consensus on Fulgent Genetics Inc.2025 Technical Patterns & Weekly Top Gainers Alerts - mfd.ru
FLGT to acquire Bako & StrataDx assets to expand pathology platform - MSN
Fulgent Genetics, Inc. (NASDAQ:FLGT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
(FLGT) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Analyst Downgrade: What are Fulgent Genetics Inc.’s technical support levelsJuly 2025 Drop Watch & Safe Capital Growth Trade Ideas - mfd.ru
Is Fulgent Genetics (NASDAQ:FLGT) A Risky Investment? - 富途牛牛
What Does The Institutional Ownership Tell Us About Fulgent Genetics? - simplywall.st
Esoteric Testing Research Report 2026 - GlobeNewswire Inc.
Fulgent Genetics: The Price Has Caught Up To Value, But I Still Like The Stock - Seeking Alpha
Breakout Move: Is Fulgent Genetics Inc a momentum stockMarket Performance Report & Accurate Intraday Trading Signals - baoquankhu1.vn
(FLGT) Risk Channels and Responsive Allocation - Stock Traders Daily
Market Review: What is the long term forecast for Fulgent Genetics Inc stock2025 Earnings Surprises & Low Risk Entry Point Tips - baoquankhu1.vn
Published on: 2026-01-19 16:33:56 - baoquankhu1.vn
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Buyout Rumor: Why Fulgent Genetics Inc stock remains undervaluedWatch List & Fast Entry and Exit Trade Plans - Bộ Nội Vụ
Why Fulgent Genetics Inc stock remains undervalued2025 Key Highlights & Community Consensus Trade Alerts - Bộ Nội Vụ
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Analysis Recap: Is ESEA stock a falling knife or bargain buy2025 Key Highlights & Smart Swing Trading Techniques - baoquankhu1.vn
Fulgent Will Acquire Two Laboratories - labusinessjournal.com
(FLGT) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Will Fulgent Genetics Inc. stock continue dividend increasesEarnings Miss & Reliable Intraday Trade Plans - Улправда
How to contact the Daily Bulletin - FinancialContent
Will Fulgent Genetics Inc. stock maintain dividend yieldBreakout Watch & Smart Money Movement Alerts - ulpravda.ru
Fulgent Genetics, Inc.Common Stock (NQ: FLGT - FinancialContent
How strong is Fulgent Genetics Inc. stock revenue growthCPI Data & Low Risk High Win Rate Picks - ulpravda.ru
Is Fulgent Genetics Inc. (7F0) stock cheap by valuation metrics2025 Bull vs Bear & Long-Term Growth Portfolio Plans - ulpravda.ru
Aug Weekly: Is Fulgent Genetics Inc. (7F0) stock cheap by valuation metricsTrade Entry Report & Free Technical Pattern Based Buy Signals - ulpravda.ru
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Large Institutional Owners Must Be Happy as Stock Continues to Impress, up 6.6% Over the Past Week - 富途牛牛
Is Fulgent Genetics Inc. (7F0) stock a fit for income portfoliosWeekly Trend Summary & Weekly Watchlist for Hot Stocks - ulpravda.ru
Health Check: How Prudently Does Fulgent Genetics (NASDAQ:FLGT) Use Debt? - simplywall.st
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. - MarketScreener
Fulgent Genetics (NASDAQ:FLGT) Stock Price Up 7.3%Time to Buy? - MarketBeat
Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates - MSN
How Fulgent Genetics Inc. stock performs in stagflation2026 world cup usa national team quarterfinals defensive leaders high defensive line match prediction breakdown - Улправда
Fulgent Genetics (NASDAQ:FLGT) vs. Mitesco (OTCMKTS:MITI) Critical Analysis - Defense World
Liquidity Mapping Around (FLGT) Price Events - Stock Traders Daily
Squarepoint Ops LLC Cuts Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform - Finviz
Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx - BioSpace
Fulgent Genetics to acquire StrataDx and selected assets of Bako Diagnostics - Medical Buyer
Fulgent Genetics to acquire select assets of Bako Diagnostics and StrataDx for $55.5m - pehub.com
Fulgent Genetics Inc Azioni (FLGT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
1.33%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):